Epistaxis Clinical Trial
Official title:
"Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"
| NCT number | NCT02517294 |
| Other study ID # | #15-17 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | June 2015 |
| Est. completion date | August 2019 |
| Verified date | January 2024 |
| Source | Nemours Children's Clinic |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Comparison is made between standard nasotracheal tubes and a specially designed nasotracheal tube during nasotracheal intubation in children undergoing general anesthesia for dental surgery.
| Status | Completed |
| Enrollment | 73 |
| Est. completion date | August 2019 |
| Est. primary completion date | August 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 3 Years to 11 Years |
| Eligibility | Inclusion Criteria: - children between the ages of 3-11, ASA 1-3, presenting to Wolfson Children's Hospital (WCH) for dental procedures requiring general anesthesia with nasotracheal intubation. Exclusion Criteria: - ASA >3 - known bleeding disorders - recent or ongoing treatment with blood-thinning medicines - frequent epistaxis - active URI/congestion/rhinorrhea - craniofacial abnormalities prohibiting NTI - known difficult airway - prior nasal surgery/trauma - allergies to any of the medicines used in this study. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Wolfson Children's Hospital | Jacksonville | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| Nemours Children's Clinic |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of Participants With Epistaxis | Mucosal damage as quantified by presence and severity of bleeding immediately after passage of the NTT through the nasopharynx. | within approximately 4hrs of surgery (day of surgery) | |
| Secondary | Number of Participants With Nasotracheal Tube Impingement | Presence and degree of severe impingement of the nasotracheal tube during nasotracheal intubation | perioperative, immediate during intervention - expected 2hrs (day of surgery) | |
| Secondary | Number of Participants With Postoperative Epistaxis | ongoing nasal bleeding in the recovery unit | Participants will be followed for the duration of the hospital stay, an expected average of 6 hours | |
| Secondary | Number of Participants With Postoperative Croup | evidence of glottic edema/injury in the immediate postoperative time frame | end of surgery until time of discharge, approximately 4hrs | |
| Secondary | Time to Discharge in Minutes | emergence from anesthesia to meeting discharge criteria, approximately 4hrs |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05334017 -
Xylometazoline and Cocaine for Nasal Vasoconstriction
|
Phase 4 | |
| Not yet recruiting |
NCT04519463 -
The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing
|
Early Phase 1 | |
| Recruiting |
NCT01886768 -
Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy
|
N/A | |
| Recruiting |
NCT00390663 -
A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
|
Phase 4 | |
| Suspended |
NCT04054687 -
Intranasal TXA for Anterior Epistaxis in the Emergency Department
|
Phase 2 | |
| Completed |
NCT02285634 -
The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
|
N/A | |
| Completed |
NCT01485224 -
Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
|
Phase 2 | |
| Completed |
NCT00793117 -
The Effect of Packing in Post Operative Management of FESS
|
Phase 4 | |
| Recruiting |
NCT06259292 -
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
|
||
| Recruiting |
NCT03850964 -
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05281952 -
Medico-economic Evaluation of Management Strategies for Severe Epistaxis
|
N/A | |
| Completed |
NCT04279288 -
The Roles of Hilotherapy in the Management of Epistaxis and Nasal Fractures
|
N/A | |
| Completed |
NCT03360045 -
Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis
|
Phase 4 | |
| Completed |
NCT03912051 -
Assessment of Performance and Safety of an Asymmetric Balloon in the Treatment of Intranasal Bleeding Managed in an Emergency Setting
|
N/A | |
| Not yet recruiting |
NCT02677467 -
Correlation Between Epistaxis and Cardiovascular Disease
|
N/A | |
| Completed |
NCT01314274 -
Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
|
Phase 2 | |
| Terminated |
NCT01051427 -
Control of Epistaxis With Surgiflo
|
N/A | |
| Completed |
NCT00863356 -
Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis
|
N/A | |
| Recruiting |
NCT05269849 -
Sirolimus for Nosebleeds in HHT
|
Phase 2 | |
| Not yet recruiting |
NCT05343650 -
NOVAPAK Nasal Packing in Shellfish Allergic Patients
|
Phase 4 |